A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
2015 ◽
Vol 1
(4)
◽
pp. 223
2020 ◽
Vol 64
(4)
◽
pp. 398-406
◽
2016 ◽
Vol 2
(2)
◽
pp. 83
1985 ◽
Vol 99
(1)
◽
pp. 18-22
◽
2009 ◽
Vol 18
(2)
◽
pp. 157-160
◽
Keyword(s):